More
    Guided Solutions - Connecting Talent With Innovation/div>

    Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309

    Financing led by Orlando Health Ventures includes a prominent group of new and existing investorsFunding supports further development of VGT-309 in lung cancer and...

    Brave Health raises $40M for Medicaid-focused virtual mental healthcare

    The company announced a $10 million Series B raise last year. Virtual mental health company Brave Health scooped up $40 million in a Series C funding round...

    Alleva scores $12M to grow behavioral health EHR

    The startup said it will use the Series A funds to continue developing its software. Alleva, which makes software geared toward behavioral health providers, raised...

    Northwell invests $3M in AI firm seeking to better understand patients’ emotions

    Northwell recently invested $3 million in Hume AI, an expressive communication research lab and AI startup. The health system is partnering with Hume to...

    Genetesis Announces Close of $17.5 Million Series C Financing

    Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing. The round was led...

    Ossiform raises capital through West Hill

    Ossiform, We Print Bone™, is pleased to announce that it has completed a £6 million capital raise through West Hill Capital. Ossiform has developed a...

    Volumina Medical closes its Series A funding

    Clinique La Prairie and Skyviews Life Science Ltd are among the new investors Volumina Medical, a spin-off from the Swiss Federal Institute of Technology in...

    Wearable Medical Devices Company Acurable Raises €11m in Series A Funding Round

    ● This investment will allow Acurable to build out its distribution network to launch its home sleep testing device AcuPebble SA100 across major European...

    CXL Ophthalmics Announces $32 Million Series A Investment Round Led by AXA IM Alts, Through its Global Health Private Equity Strategy

    CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, announced it has raised a $32 million Series A funding round...

    Latest articles